Role of vindesine in induction chemotherapy in locally-advanced non- small-cell lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 1, 1998, Pages 4-9

  Fischer, Jürgen R ^a   Drings, Peter ^a  

^a LVA Baden ^*  (Germany)

Author keywords

Induction chemotherapy; Non small cell lung cancer; Vindesine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MITOMYCIN; MITOMYCIN C; VINBLASTINE; VINDESINE;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SEPSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME; VINDESINE;

EID: 0031933294     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050126     Document Type: Review

References (32)

1. Arcangeli G, Zaniboni A, Milano S, et al (1993) MICE: a new active combination for non-small cell lung cancer. Eur J Cancer 29A:1848-1850
2. Bitran JD, Vokes EE, Hoffmann PC, et al (1992) Neoadjuvant therapy for stage III non small cell lung cancer: a review. In: Bernal SD, Hesketh PJ (eds) Lung cancer differentiation, vol 58. Dekker, New York, pp 293-304
3. Blanke CD, Johnson DH (1995) Combined modalty therapy in non-small cell lung cancer. Curr Opin Oncol 7:144-149
4. Burkes RL, Ginsberg RJ, Shepherd FA, et al (1992) Induction chemotherapy with mitomycin, vindesine and cisplatin for stage III unresectable non small cell lung cancer: results of the Toronto phase II trial. J Clin Oncol 10:580-586
5. Crino L, Clerici M, Figoli F, et al (1995) Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann Oncol 6:347-353
6. Cullen MH, Joshi R, Chetiyawardana AD, Woodroffe CM (1988) Mitomycin, ifosfamide and cis-platin in non-small cell lung cancer: treatment good enough to compare. Br J Cancer 58:359-361
7. Donnadieu N, Paesmans M, Sculier JP (1991) Chemotherapy of non-small-cell lung cancer according to disease extent: a meta-analysis of the literature. Lung cancer 7:243-252
8. Drings P, Vogt-Moykopf I (1992) Pulmonary resection following chemotherapy. In: Peters RM, Toledo J (eds) Current topics in general thoracic surgery, vol 2. Perioperative care. Elsevier Science, Amsterdam, pp 197-209
9. Einhorn LH, Loehrer PJ, Williams SD, et al (1986) Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer. J Clin Oncol 4:1037-1043
10. Fischer JR, Manegold C, Bülzebruck H, Vogt-Moykopf I, Drings P (1994) Induction chemotherapy with and without R-me-tHuG-CSF support in locally advanced stage IIIA/B non small cell lung cancer. Semin Oncol 21:20-27
11. Fischer JR, Müller A, Bülzebruck H, et al (1996) Induction chemotherapy with and without G-CSF in stage IIIA/B non-small cell lung cancer: 7 year follow up (abstract 1195). Proc Am Soc Clin Oncol 15:395
12. Fukuoka M, Masuda N, Furuse K, et al (1991) A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin. J Clin Oncol 9:606-613
13. Ginsberg RJ (1995) Neoadjuvant (induction) treatment for non-small cell lung cancer. Lung Cancer 12 [Suppl 2]:S33-S40
14. Goldberg M, Burkes RL (1993) Induction chemotherapy for stage IIIA unresectable non small cell lung cancer: The Toronto experience and overview. Semin Surg Oncol 9:108-113
15. Gralla RJ (1988) Preoperative and adjuvant chemotherapy in non-small cell lung cancer. Semin Oncol 15 [Suppl 7]:8-12
16. Johnson MR (1988) Selecting patients with lung cancer for surgical therapy. Semin Oncol 15:246-254
17. Kris MG, Gralla RJ, Martini N, Stampleman LV, Burke TM (1987) Preoperative and adjuvant chemotherapy in locally advanced non small cell lung cancer. Surg Clin North Am 67:1051-1059
18. Martini N, Kris MG, Gralla RJ, et al (1988) The effects of preoperative chemotherapy on the resectability of non small cell lung carcinoma with mediastinal lymph nodes metastases (N2M0). Ann Thorac Surg 45:370-379
19. Martini N, Kris MG, Flehinger BJ, et al (1993) Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55:1365-1374
20. Perez CA, Stanley K, Grundy G (1982) Impact of irradiation technique and tumor extend in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 50:1091-1099
21. Perol M, Guerin JC, Thomas P, et al (1996) Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. Lung Cancer 14:119-134
22. Pisters KM, Kris MG, Gralla RF, Martini N (1990) Paraoperative chemotherapy in non small cell lung cancer. An analysis of a trial in patients with clinically stage IIIA apparent mediastinal lymph node involvement. In: Salmon SE (ed) Adjuvant therapy of cancer. Saunders, Philadelphia, pp 125-132
23. Pujol JL, Hayot M, Rouanet P, et al (1994) Long-term results of neoadjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer. Chest 106:1451-1455
24. Rosell R, Gómez-Codina J, Camps C, et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330:153-158
25. Roth JA, Fossella F, Komaki R, et al (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86:673-680
26. Ruckdeschel JC, Finkelstein DM, Ettinger DS, et al (1986) A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. J Clin Oncol 4:14-22
27. Skarin A, Socinski MA, Kalish L, Frei E III (1989) Neoadjuvant therapy for stage IIIa non small cell lung cancer (NSCLC) (abstract 941). Proc Am Soc Clin Oncol 8:241
28. Spain RC (1988) Neoadjuvant mitomycin C, cisplatin and infusion vinblastine in locally and regionally advanced non small cell lung cancer: problems and progress from the perspective of long term follow up. Semin Oncol 15:6-15
29. Thomas P, Kleisbauer J-P, Perol M, et al (1993) Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer Groupe Francais de Pneumo-Cancérologie (GFPC). Eur J Cancer 29A:477
30. Vogt-Moykopf I, Bülzebruck H, Probst G, et al (1988) Chirurgische Therapie des Bronchialkarzinoms. Langenbecks Arch Chir ii 109-117
31. Vokes EE, Bitran JD, Hoffman PC, et al (1989) Neoadjuvant vindesine, etoposide and cisplatin for locally advanced non small cell lung cancer. Final report of a phase II study. Chest 96:110-113
32. Weick JK, Crowley J, Natale RB, et al (1991) A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 9:1157-1162